Woodworth, M. H., et al. Fecal microbiota transplantation promotes reduction of antimicrobial resistance by strain replacement. Sci Transl Med 15, eabo2750 (2023).
Smith, J. R. et al. b-lactam combinations with daptomycin provide synergy against vancomycin-resistant Enterococcus faecalis and Enterococcus faecium. J Antimicrob Chemother 70, 1738–1743 (2015).
Chacra, L. A. & Fenollar, F. Exploring the global vaginal microbiome and its impact on human health. Microb. Pathog. 160, 105172 (2021).
Wei, X., et al. Vaginal microbiomes show ethnic evolutionary dynamics and positive selection of Lactobacillus adhesins driven by a long-term niche-specific process. Cell Rep 43, 114078 (2024).
Chen, C., et al. The microbiota continuum along the female reproductive tract and its relation to uterine-related diseases. Nat Commun 8, 875 (2017).
Bonneton, M., et al. Bacterial vaginosis and other infections in pregnant women in Senegal. BMC Infect Dis 21, 1090 (2021).
Tang, W. et al. Pregnancy and fertility-related adverse outcomes associated with Chlamydia trachomatis infection: a global systematic review and meta-analysis. Sex Transm Infect 96, 322–329 (2020).
Brennan, C. et al. Harnessing the power within: engineering the microbiome for enhanced gynecologic health. Reprod Fertil 5, e230060 (2024).
D’Costa, V. M., McGrann, K. M., Hughes, D. W. & Wright, G. D. Sampling the antibiotic resistome. Science 311, 374–377 (2006).
Kim, D.-W. & Cha, C.-J. Antibiotic resistome from the One-Health perspective: understanding and controlling antimicrobial resistance transmission. Exp. Mol. Med. 53, 301–309 (2021).
Peebles, K., Velloza, J., Balkus, J. E., McClelland, R. S. & Barnabas, R. V. High global burden and costs of bacterial vaginosis: a systematic review and meta-analysis. Sex Transm Dis 46, 304–311 (2019).
Ravel, J. et al. Vaginal microbiome of reproductive-age women. PNAS 108, 4680–4687 (2010).
Laniewski, P. & Herbst-Kralovetz, M. M. Bacterial vaginosis and health-associated bacteria modulate the immunometabolic landscape in 3D model of human cervix. Npj Biofilms Microbiomes 7, 88 (2021).
Machado, A. & Cerca, N. Influence of biofilm formation by Gardnerella vaginalis and other anaerobes on bacterial vaginosis. J Infect Dis 212, 1856–1861 (2015).
Rosca, A. S. et al. In vitro interactions within a biofilm containing three species found in bacterial vaginosis (BV) support the higher antimicrobial tolerance associated with BV recurrence. J Antimicrob Chemother 77, 2183–2190 (2022).
Rosca, A. S., et al. Six bacterial vaginosis-associated species can form an in vitro and ex vivo polymicrobial biofilm that is susceptile to Thymbra capitata essential oil. Front Cell Infect Microbiol 12, 824860 (2022).
Johnston, W., et al. In vitro bacterial vaginosis biofilm community manipulation using endolysin therapy. Biofilm 5, 100101 (2023).
Gao, M., Manos, J., Whiteley, G. & Zablotska-Manos, &I. Antibiofilm agents for the treatment and prevention of bacterial vaginosis: a systematic narrative review. J Infect Dis 230, e508–e517 (2024).
Castro, J. et al. Exploiting the anti-biofilm effect of the engineered phage endolysin PM-477 to disrupt in vitro single- and dual-species biofilms of vaginal pathogens associated with bacterial vaginosis. Antibiotics 11, 558 (2022).
Menard, J.-P. Antibacterial treatment of bacterial vaginosis: current and emerging therapies. Int J Womens Health 3, 295–305 (2011).
Bradshaw, C. S. et al. High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence. J Infect Dis 193, 1478–1486 (2006).
Muzny, C. A. & Schwebke, J. R. Biofilms: an underappreciated mechanism of treatment failure and recurrence in vaginal infections. Clin Infect Dis 61, 601–606 (2015).
Castro, J. et al. Comparative transcriptomic analysis of Gardnerella vaginalis biofilms vs. planktonic cultures using RNA-seq. Npj Biofilms Microbiome 3, 3 (2017).
Madsen, J. S., Burmolle, M., Hansen, L. H. & Sorensen, &S. J. The interconnection between biofilm formation and horizontal gene transfer. FEMS Immunol. Med. Microbiol. 65, 183–195 (2012).
Maestre-Carballa, L., Navarro-Lopez, V. & Martinez-Garcia, M. A resistome roadmap: From the human body to pristine environments. Front Microbiol 13, 858831 (2022).
Huang, R. et al. Molecular evolution of the tet(M) gene in Gardnerella vaginalis. J Antimicrob Chemother 40, 561–565 (1997).
Pekmezovic, M. et al. Candida pathogens induce protective mitochondria-associated type I interferon signalling and a damage-driven response in vaginal epithelial cells. Nat Microbiol 6, 643–657 (2021).
Paladine, H. L. & Desai, U. A. Vaginitis: Diagnosis and Treatment. Am Fam Physician 97, 321–329 (2018).
Pan, Y., et al. Candida causes recurrent vulvovaginal candidiasis by forming morphologically disparate biofilms on the human vaginal epithelium. Biofilm 6, 100162 (2023).
Liu, H. Y., Prentice, E. L. & Webber, M. A. Mechanisms of antimicrobial resistance in biofilms. Npj Antimicrob. Resist. 2, 27 (2024).
Vazquez, J. A. et al. Stable phenotypic resistance of Candida species to Amphotericin B conferred by prexposure to subinhibitory levels of azoles. J Clin Microbiol 36, 2690–2695 (1998).
Partha, A. D. S. L., Widodo, A. D. W. & Endraswari, P. D. Evaluation of fluconazole, itraconazole, and voriconazole activity on Candida albicans: A case control study. Ann. Med Surg 84, 104882 (2022).
Barbee, L. A. & Cyr, S. B. S. Management of Neisseria gonorrhoeae in the United States: Summary of evidence from the development of the 2020 Gonorrhea treatment recommendations and the 2021 Centers for Disease Control and Prevention sexually transmitted infection treatment guidelines. Clin Infect Dis 74, S95–S111 (2022).
Muhammad, I., et al. Characterisation of blaTEM genes and types of b-lactamase plasmids in Neisseria gonorrhoeae – the prevalent and conserved blaTEM-135 has not recently evolved and existed in the Toronto plasmid from the origin. BMC Infect Dis 14, 454 (2014).
Mlynarczyk-Bonikowska, B., Kujawa, M., Malejczyk, M., Mlynarczyk, G. & Majewski, S. Plasmid-mediated resistance to tetracyclines among Neisseria gonorrhoeae strains isolated in Poland between 2012 and 2013. Postepy Dermatol Alergol 33, 475–479 (2016).
Osawa, K. et al. penA, ponA, porB1, and mtrR mutations and molecular epidemiological typing of Neisseria gonorrhoeae with decreased susceptibility to cephalosporins. Antimicrob Agents Chemother 61, e01174–17 (2017).
Benamri, I., Azzouzi, M., Sanak, K., Moussa, A. & Radouani, F. An overview of genes and mutations associated with Chlamydiae species’ resistance to antibiotics. Ann Clin Microbiol Antimicrob 20, 59 (2021).
Greiner, L. L. et al. Biofilm formation by Neisseria gonorrhoeae. Infect Immun 73, 1964–1970 (2005).
Sapi, E. et al. Borrelia and Chlamydia can form mixed biofilms in infected human skin tissues. Eur J Microbiol Immunol 9, 46–55 (2019).
Tantalo, L. C. et al. Antimicrobial susceptibility of Treponema pallidum subspecies pallidum: an in-vitro study. Lancet Microbe 4, e994–e1004 (2023).
Sirichoat, A. et al. Antibiotic resistance-susceptibility profiles of Enterococcus faecalis and Streptococcus spp. from the human vagina, and genome analysis of the genetic basis of intrinsic and acquired resistances. Front Microbiol 11, 1438 (2020).
Monroy-Perez, E. et al. Virulence gene transcription, phylogroups, and antibiotic resistance of cervico-vaginal pathogenic E. coli in Mexico. PLoS One 15, e0234730 (2020).
Khazaei, Z., Ghorbani, P., Namaei, M. H., Rezaei, Y. & Yousefi, M. Prevalence of Escherichia coli K1 rectovaginal colonization among pregnant women in Iran: virulence factors and antibiotic resistance properties. Microb Drug Resist 26, 1201–1207 (2020).
Paniagu-Contreras, G. L. et al. O-serogroups of multi-drug resistant cervicovaginal Escherichia coli harboring a battery of virulence genes. J Infect Chemo 25, 494–497 (2019).
Chadwick, S. G., Hart, C. E., Mordechai, E., Adelson, M. E. & Gygax, S. E. Staphylococcal cassette chromosome mec type and antibiotic susceptibility profiles of vaginal and nonvaginal MRSA clinical isolates. Diagn. Microbio Infect Dis 74, 210–212 (2012).
Otaguiri, E. S., et al. Development of a melting-curve based multiplex real-time PCR assay for simultaneous detection of Streptococcus agalactiae and genes encoding resistance to macrolides and lincosamides. BMC Pregnancy Childbirth 18, 126 (2018).
Domelier, A.-S. et al. Molecular characterization of erythromycin-resistant Streptococcus agalactiae strains. J Antimicrob Chemother 62, 1227–1233 (2008).
Lee, W.-T. & Lai, M.-C. High prevalence of Streptococcus agalactiae from vaginas of women in Taiwan and its mechanisms of macrolide and quinolone resistance. J Microbiol Immunol Infect 48, 510–516 (2015).
Stsepetova, J. et al. Assessment of phenotypic and genotypic antibiotic susceptibility of vaginal Lactobacillus sp. J Appl Microbiol 123, 524–534 (2017).
Jeters, R. T. et al. Antibiotic resistance genes in the vaginal microbiota of primates not normally exposed to antibiotics. Microb Drug Resist 15, 309–315 (2009).
Zhang, J., et al. Molecular detection of colistin resistance genes (mcr-1 to mcr-5) in human vaginal swabs. BMC Res Notes 11, 143 (2018).
Deng, Y., et al. Horizontal gene transfer contributes to virulence and antibiotic resistance of Vibrio harveyi 345 based on complete genome sequence analysis. BMC Genomics 20, 761 (2019).
Sezmis, A. L., Woods, L. C., Peleg, A. Y. & McDonald, M. J. Horizontal gene transfer, fitness costs and mobility shape the spread of antibiotic resistance genes into experimental populations of Acinetobacter Baylyi. Mol Biol Evol 40, msad028 (2023).
McInnes, R. S., McCallum, G. E., Lamberte, L. E. & van Schaik, W. Horizontal transfer of antibiotic resistance genes in the human gut microbiome. Curr Opin Microbiol 53, 35–43 (2020).
Partridge, S. R., Kwong, S. M., Firth, N. & Jensen, S. O. Mobile genetic elements associated with antimicrobial resistance. Clin Microbiol Rev 31, e00088–17 (2018).
Li, X., et al. Co-localization of antibiotic resistance genes is widespread in the infant gut microbiome and associated with an immature gut microbial composition. Microbiome 12, 87 (2024).
Grodner, B. et al. Spatial mapping of mobile genetic elements and their bacterial hosts in complex microbiomes. Nat Microbiol 9, 2262–2277 (2024).
Shi, H. et al. Highly multiplexed spatial mapping of microbial communities. Nature 588, 676–681 (2020).
Kent, A. G., Vill, A. C., Shi, Q., Satlin, M. J. & Brito, I. L. Widespread transfer of mobile antibiotic resistance genes within individual gut microbiomes revealed through bacterial Hi-C. Nat Commun 11, 4379 (2020).
Kalmar, L. et al. HAM-ART: an optimised culture-free Hi-C metagenomics pipeline for tracking antimicrobial resistance genes in complex microbial communities. PLoS Genet 18, e1009776 (2022).
McCallum, G. E. et al. Noise reduction strategies in metagenomic chromosome confirmation capture to link antibiotic resistance genes to microbial hosts. Microb Genom 9, mgen001030 (2023).
Yaffe, E. & Relman, D. A. Tracking microbial evolution in the human gut using Hi-C reveals extensive horizontal gene transfer, persistence and adaptation. Nat Microbiol 5, 343–353 (2020).
Oshima, K. et al. Complete genome sequence of Gardnerella vaginalis strain JCM 11026, isolated from vaginal tracts of women. Genome Announc 3, e00286–15 (2015).
Ahmed A. et al. Comparative genomic analyses of 17 clinical isolates of Gardnerella vaginalis provide evidence of multiple genetically isolated clades consistent with subspeciation into Genovars. J Bacteriol. 194, 3922–3937.
Bohr, L. L., Mortimer, T. D. & Pepperell, C. S. Lateral gene transfer shapes diversity of Gardnerella spp. Front Cell Infect Microbiol 10, 293 (2020).
Yeoman, C. J. et al. Comparative genomics of Gardnerella vaginalis strains reveals substantial differences in metabolic and virulence potential. PLoS One 5, e12411 (2010).
Ito, Y., et al. The emergence of metronidazole-resistant Prevotella bivia harboring nimK gene in Japan. Microbiol Spectr 12, e00562-24 (2024).
Ojala, T., et al. Comparative genomics of Lactobacillus crispatus suggests novel mechanisms for the competitive exclusion of Gardnerella vaginalis. BMC Genomics 15, 1070 (2014).
Manoharan-Basil, S. S., Gestels, Z., Abdellati, S., Akomoneh, E. A. & Kenyon, C. Evidence of horizontal gene transfer within porB in 19 018 whole-genome Neisseria spp. isolates: a global phylogenetic analysis. Microb Genom 9, mgen001041 (2023).
Manoharan-Basil, S. S., et al. Evidence of horizontal gene transfer of 50S ribosomal genes rplB, rplD, and rplY in Neisseria gonorrhoeae. Front Microbiol 12, 683901 (2021).
Kim, H., Kwak, W., Yoon, S. H., Kang, D.-K. & Kim, H. Horizontal gene transfer in Chlamydia: novel insights from tree reconciliation. PLoS One 13, e0195139 (2018).
Hull, C. M. & Heitman, J. Fungal mating: Candida albicans flips a switch to get in the mood. Curr Biol 12, R782–R784 (2002).
Slutsky, B. et al. ‘White-opaque transition’: a second high-frequency switching system in Candida albicans. J Bacteriol 169, 189–197 (1987).
Sun, Y. et al. pH regulates white-opaque switching and sexual mating in Candida albicans. Eukaryot Cell 14, 1127–1134 (2015).
Duggan, S. & Usher, J. Candida glabrata: A powerhouse of resistance. PLoS Pathog 19, e1011651 (2023).
Polakova, S. et al. Formation of new chromosomes as a virulence mechanism in yeast Candida glabrata. PNAS 106, 2688–2693 (2009).
Fettweis, J. M. et al. Differences in vaginal microbiome in African American women versus women of European ancestry. Microbiol. Read. 160, 2272–2282 (2014).
Jasarevic, E., et al. The composition of human vaginal microbiota transferred at birth affects offspring health in a mouse model. Nat Commun 12, 6289 (2021).
Vargas-Robles, D., et al. Changes in the vaginal microbiota across a gradient of urbanization. Sci Rep 10, 12487 (2020).
Musa, J., et al. Vaginal microbiome community state types and high-risk human papillomaviruses in cervical precancer and cancer in North-central Nigeria. BMC Cancer 23, 683 (2023).
Roachford, O. S. E., Alleyne, A. T., Kuelbs, C., Torralba, M. G. & Nelson, K. E. The cervicovaginal microbiome and its resistome in a random selection of Afro-Caribbean women. Hum. Microbiome J. 20, 100079 (2021).
Navarro, S. et al. Glycogen availability and pH variation in a medium simulating vaginal fluid influence the growth of vaginal Lactobacillus species and Gardnerella vaginalis. BMC Microbiol 23, 186 (2023).
Achilles, S. L. et al. Impact of contraceptive initiation on vaginal microbiota. Am J Obstet Gynecol 218, 622.e1–622.e10 (2018).
Gajer, P. et al. Temporal dynamics of the human vaginal microbiota. Sci Transl Med 4, 132ra52 (2012).
Schroeder, H. A. et al. Herpes simplex virus binding IgG traps HSV in human cervicovaginal mucus across the menstrual cycle and diverse vaginal microbial composition. Mucosal Immunol 11, 1477–1486 (2018).
Song, S. D., et al. Daily vaginal microbiota fluctuations associated with natural homonal cycle, contraceptives, diet, and exercise. mSphere 5, 1128 (2020).
Reynoso-Prieto, M. et al. Menstrual cycle-dependent alterations in glycosylation: a roadmap for defining biomarkers of favorable and unfavorable mucus. J Assist Reprod Genet 36, 847–855 (2019).
Hoang, T. et al. The cervicovaginal mucus barrier to HIV-1 is diminished in bacterial vaginosis. PLoS Pathog 16, e1008236 (2020).
Zuend, C. F., et al. Increased genital mucosal cytokines in Canadian women associate with higher antigen-presenting cells, inflammatory metabolites, epithelial barrier disruption, and the depletion of L. crispatus. Microbiome 11, 159 (2023).
Kindinger, L. M. et al. Relationship between vaginal microbial dysbiosis, inflammation, and pregnancy outcomes in cervical cerclage. Sci Transl Med 8, 350ra102 (2016).
Rosati, D. et al. An exaggerated monocyte-derived cytokine response to Candida hyphae in patients with recurrent vulvovaginal candidiasis. J Infect Dis 225, 1796–1806 (2020).
Choi, J. et al. 2023 Korean sexually transmitted infections guidelines for non-gonococcal bacterial infection (chlamydia, syphilis, etc.) by the Korean Association of Urogenital Tract Infection and Inflammation. Investig Clin Urol 65, 115–123 (2024).
Zierden, H. C., et al. Cervicovaginal mucus barrier properties during pregnancy are impacted by the vaginal microbiome. Front Cell Infect Microbiol 13, 1015625 (2023).
Sigeti, J. S., Guiney, D. G. Jr & Davis, C. E. Mechanism of action of metronidazole on Bacteroides fragilis. J Infect Dis 148, 1083–1089 (1983).
Smieja, M. Current indications for the use of clindamycin: A critical review. Can J Infect Dis 9, 22–28 (1998).
Bistoletti, P., Fredricsson, B., Hagstrom, B. & Nord, C. E. Comparison of oral and vaginal metronidazole therapy for nonspecific bacterial vaginosis. Gynecol Obstet Invest 21, 144–149 (1986).
Sorgo, A. G. et al. Effects of fluconazole on the secretome, the wall proteome, and wall integrity of the clinical fungus Candida albicans. Eukaryot Cell 10, 1071–1081 (2011).
Won, E. J. et al. Fluconazole-resistant Candida glabrata bloodstream isolates, South Korea, 2008-2018. Emerg Infect Dis 27, 779–788 (2021).
Kang, X., et al. Evaluation of the activity of antimicrobial peptides against bacterial vaginosis. Open Life Sci 19, 20220927 (2024).
Lin, W.-C., Chen, Y.-R., Chuang, C.-M. & Chen, J.-Y. A cationic amphipathic Tilapia piscidin 4 peptide-based antimicrobial formulation promotes eradication of bacterial vaginosis-associated bacterial biofilms. Front Microbiol 13, 3389 (2022).
Zhou, Y. et al. Newly discovered antimicrobial peptide Scyampcin44-63 from Scylla paramamosain exhibits a multitargeted Candidacidal mechanism in vitro and is effective in a murine model of vaginal candidiasis. Antimicrob Agents Chemother 67, e0002223 (2023).
Kocendova J. et al. Antifungal activity of analogues of antimicrobial peptides isolated from bee venoms against vulvovaginal Candida spp. FEMS Yeast Res. 19, foz013 (2019).
Woodburn, K. W. et al. Designed antimicrobial peptides for recurrent vulvovaginal candidiasis treatment. Antimicrob Agents Chemother 63, e02690-18 (2019).
Yasin, B., Pang, M., Lehrer, R. I. & Wagar, E. A. Activity of Novispirin G-10, a novel antimicrobial peptide against Chlamydia trachomatis and vaginosis-associated bacteria. Exp Mol Pathol 74, 190–195 (2003).
Lazarev, V. N. et al. Antimicrobial peptide from spider venom inhibits Chlamydia trachomatis infection at an early stage. Arch Microbiol 195, 173–179 (2013).
Lee, S. G. et al. 17BIPHE2, an engineered cathelicidin antimicrobial peptide with low susceptibility to proteases, is an effective spermicide and microbicide against Neisseria gonorrhoeae. Hum Reprod 37, 2503–2517 (2022).
Lee, S. G., Kiattiburut, W., Schinkel, S. C. B., Angel, J. & Tanphaichitr, N. Safety of multiple administrations of spermicidal LL-37 antimicrobial peptide into the mouse female reproductive tract. Mol Hum Reprod 29, gaad023 (2023).
Sobel, J. D., Chaim, W., Nagappan, V. & Leaman, D. Treatment of vaginitis caused by Candida glabrata: use of topical boric acid and flucytosine. Am J Obstet Gynecol 189, 1297–1300 (2003).
Surapaneni, S., Akins, R. & Sobel, J. D. Recurrent bacterial vaginosis: an unmet therapeutic challenge. Experience with a combination pharmacotherapy long-term suppressive regimen. Sex Transm Dis 48, 761–765 (2021).
De Seta, F., Schmidt, M., Vu, B., Essmann, M. & Larsen, B. Antifungal mechanisms supporting boric acid therapy of Candida vaginitis. J Antimicrob Chemother 63, 325–336 (2009).
Schmidt, M., Tran-Nguyen, D. & Chizek, P. Influence of boric acid on energy metabolism and stress tolerance of Candida albicans. J Trace Elem Med Biol 49, 140–145 (2018).
Cohen, C. R. et al. Randomized trial of Lactin-V to prevent recurrence of bacterial vaginosis. N Engl J Med 382, 1906–1915 (2020).
Vicariotto, F., Mogna, L. & Del Piano, M. Effectiveness of the two microorganisms Lactobacillus fermentum LF15 and Lactobacillus plantarum LP01, formulated in slow-release vaginal tablets, in women affected by bacterial vaginosis: a pilot study. J Clin Gastroenterol 48, S106–S112 (2014).
Russo, R., Karadja, E. & De Seta, F. Evidence-based mixture containing Lactobacillus strains and lactoferrin to prevent recurrent bacterial vaginosis: a double blind, placebo controlled, randomised clinical trial. Benef Microbes 10, 19–26 (2019).
Elsharkawy, I. et al. Continuous versus interrupted use of vaginal probiotics plus vaginal clindamycin cream for bacterial vaginosis: a randomized controlled study. J Matern Fetal Neonatal Med 34, 58–65 (2021).
Hemmerling, A., Wierzbicki, M. R., Armstrong, E. & Cohen, C. R. Response to antibiotic treatment of bacterial vaginosis predicts the effectiveness of LACTIN-V (Lactobacillus crispatus CTV-05) in the prevention of recurrent disease. Sex Transm Dis 51, 437–440 (2024).
Ya, W., Reifer, C. & Miller, L. E. Efficacy of vaginal probiotic capsules for recurrent bacterial vaginosis: a double-blind, randomized, placebo-controlled study. Am J Obstet Gynecol 203, 120.e1–120.e6 (2010).
Murina, F., Graziottin, A., Vicariotto, F. & De Seta, F. Can Lactobacillus fermentum LF10 and Lactobacillus acidophilus LA02 in a slow-release vaginal product be useful for prevention of recurrent vulvovaginal candidiasis?: A clinical study. J Clin Gastroenterol 48, S102–S105 (2014).
Russo, R., Superti, F., Karadja, E. & De Seta, F. Randomised clinical trial in women with recurrent vulvovaginal candidiasis: efficacy of probiotics and lactoferrin as maintenance treatment. Mycoses 62, 328–335 (2019).
Mollazadeh-Narestan, Z. et al. Comparing the effect of probiotic and fluconazole on treatment and recurrence of vulvovaginal candidiasis: a triple-blinded randomized controlled trial. Probiotics Antimicrob Proteins 15, 1436–1446 (2023).
Vladareanu, R. et al. New evidence on oral L. plantarum P17630 product in women with history of recurrent vulvovaginal candidiasis (RVVC): a randomized double-blind placebo-controlled study. Eur Rev Med Pharmacol Sci 22, 262–267 (2018).
Davar, R. et al. Comparing the recurrence of vulvovaginal candidiasis in patients undergoing prophylactic treatment with probiotic and placebo during the 6 months. Probiotics Antimicrob Proteins 8, 130–133 (2016).
Ang, X.-Y. et al. Lactobacilli reduce recurrences of vaginal candidiasis in pregnant women: a randomized, double-blind, placebo-controlled study. J Appl Microbiol 132, 3168–3180 (2022).
Rezazadeh, M. B., Zanganeh, M., Jarahi, L. & Fatehi, Z. Comparative efficacy of oral and vaginal probiotics in reducing the recurrence of bacterial vaginosis: a double-blind clinical trial. BMC Womens Health 24, 575 (2024).
Mandar, R. et al. Impact of Lactobacillus crispatus-containing oral and vaginal probiotics on vaginal health: a randomised double-blind placebo controlled clinical trial. Benef Microbes 14, 143–152 (2023).
Karpinets, T. V. et al. Effect of antibiotics on gut and vaginal microbiomes associated with cervical cancer development in mice. Cancer Prev Res 13, 997–1006 (2020).
Koirala, R., et al. Effect of oral consumption of capsules containing Lactobacillus paracasei LPC-S01 on the vaginal microbiota of healthy adult women: a randomized, placebo-controlled, double-blind crossover study. FEMS Microbiol Ecol 96, fiaa084 (2020).
Reznichenko, H. et al. Oral intake of Lactobacilli can be helpful in symptomatic bacterial vaginosis: A randomized clinical study. J Low Genit Tract Dis 24, 284–289 (2020).
Lev-Sagie, A. et al. Vaginal microbiome transplantation in women with intractable bacterial vaginosis. Nat Med 25, 1500–1504 (2019).
Bordigoni, A., Bouchard, S. & Desnues, C. Isolation and characterization of Gardnerella phage vB_Gva_AB1, a bacteriophage infecting a clinical strain of Gardnerella vaginalis. Microbiol Resour Announc 10, 1128 (2021).
Arroyo-Moreno, S., Cummings, M., Corcoran, D. B., Coffey, A. & McCarthy, R. R. Identification and characterization of novel endlysins targeting Gardnerella vaginalis biofilms to treat bacterial vaginosis. Npj Biofilms Microbiomes 8, 29 (2022).
Landlinger, C. et al. Engineered phage endolysin eliminates Gardnerella biofilm without damaging beneficial bacteria in bacterial vaginosis ex vivo. Pathogens 10, 54 (2021).
Pirnay, J.-P. et al. Personalized bacteriophage therapy outcomes for 100 consecutive cases: a multicentre, multinational, retrospective observational study. Nat Microbiol 9, 1434–1453 (2024).
Bhattarai, S. R., Yoo, S. Y., Lee, S.-W. & Dean, D. Engineered phage-based therapeutic materials inhibit Chlamydia trachomatis intracellular infection. Biomater 33, 5166–5174 (2012).
Orazi, G., Collins, A. J. & Whitaker, R. J. Prediction of prophages and their host ranges in pathogenic and commensal Neisseria species. mSystems 7, e00083–22 (2022).
Suh, G. A., et al. Considerations for the use of phage therapy in clinical practice. Antimicrob Agents Chemo 66, e0207121 (2022).
Lopatkin, A. J., et al. Clinically relevant mutations in core metabolic genes confer antibiotic resistance. Science 371, eaba0862 (2021).
Bhargava, P. & Collins, J. J. Boosting bacterial metabolism to combat antibiotic resistance. Cell Metab 21, 154–155 (2015).
Kok, M., Maton, L., van der Peet, M., Hankemeier, T. & van Hasselt, J. G. C. Unraveling antimicrobial resistance using metabolomics. Drug Discov. Today 27, 1774–1783 (2022).
Lempp, M., et al. Systematic identification of metabolites controlling gene expression in E. coli. Nat Commun 10, 4463 (2019).
Meylan, S. et al. Carbon sources tune antibiotic susceptibility in Pseudomonas aeruginosa via tricarboxylic acid cycle control. Cell Chem. Biol. 24, 195–206 (2017).
Su, Y. -b, Peng, B., Han, Y., Li, H. & Peng, X.-X. Fructose restores susceptibility of multidrug-resistant Edwardsiella tarda to Kanamycin. J Proteome Res 14, 1612–1620 (2015).
Peng, B. et al. Exogenous alanine and/or glucose plus Kanamycin kills antibiotic-resistant bacteria. Cell Metab 21, 249–261 (2015).
Sinha, A. K. et al. Dietary fibre directs microbial tryptophan metabolism via metabolic interactions in the gut microbiota. Nat Microbiol 9, 1964–1978 (2024).
Banerjee, D. et al. A scalable metabolite supplementation strategy against antibiotic resistant pathogen Chromobacterium violaceum induced by NAD+/NADH+ imbalance. BMC Syst. Biol. 11, 51 (2017).
Bhandari, P. & Hill, J. E. Transport and utilization of glycogen breakdown products by Gardnerella spp. from the human vaginal microbiome. Microbiol Spectr 11, e04435–22 (2023).
Zhang, K., et al. Antibiotic resistance and pathogenicity assessment of various Gardnerella sp. strains in local China. Front Microbiol 13, 1009798 (2022).
Sulaiman, J. E. & Lam, H. Proteomics in antibiotic resistance and tolerance research: Mapping the resistome and the tolerome of bacterial pathogens. Proteomics 22, e2100409 (2022).
Masuda, T., Mori, A., Ito, S. & Ohtsuki, S. Quantitative and targeted proteomics-based identification and validation of drug efficacy biomarkers. Drug Metab. Pharmacokinet. 36, 100361 (2021).
Zhu, M. et al. Vaginal Lactobacillus fatty acid response mechanisms reveal a metabolite-targeted strategy for bacterial vaginosis treatment. Cell 187, 5413–5430.e29 (2024).
Bloom, S. M. et al. Cysteine dependence of Lactobacillus iners is a potential therapeutic target for vaginal microbiota modulation. Nat Microbiol 7, 434–450 (2022).
Castro, J. et al. Reciprocal interference between Lactobacillus spp. and Gardnerella vaginalis on initial adherence to epithelial cells. Int J Med Sci 10, 1193–1198 (2013).
Srinivasan, S. et al. Metabolic signatures of bacterial vaginosis. mBio 6, e00204–e00215 (2015).
Bokulich, N. A. et al. Multi-omics data integration reveals metabolome as the top predictor of the cervicovaginal microenvironment. PLoS Comput Biol 18, e1009876 (2022).
Oliver, A., et al. Cervicovaginal microbiome composition is associated with metabolic profiles in healthy pregnancy. mBio 11, e01851-20 (2020).
Challa, A. et al. Multi-omics analysis identifies potential microbial and metabolite diagnostic biomarkers of bacterial vaginosis. J Euro Acad Derm Venereol 38, 1152–1165 (2024).
Donia, M. S. et al. A systematic analysis of biosynthetic gene clusters in the human microbiome reveals a common family of antibiotics. Cell 158, 1402–1414 (2014).
Kim, H. R. et al. Isolation, structure elucidation, total synthesis, and biosynthesis of dermazolium A, an antibacterial imidazolium metabolite of a vaginal bacterium Dermabacter vaginalis. Arch. Pharmacal Res 46, 35–43 (2023).
Bonnardel, F. et al. Proteome-wide prediction of bacterial carbohydrate-binding proteins as a tool for understanding commensal and pathogen colonisation of the vaginal microbiome. Npj Biofilms Microbiomes 7, 49 (2021).
Singh, S. et al. Antimicrobial resistance studies using Raman spectroscopy on clinically relevant bacterial strains. Anal Chem 95, 11342–11351 (2023).
Ma, L., Chen, L., Chou, K. C. & Lu, X. Campylobacter jejuni antimicrobial resistance profiles and mechanisms determined using a Raman spectroscopy-based metabolomic approach. Appl Env. Microbiol 87, e0038821 (2021).
Pavlicek, R. L., Crane, N. J., Ghebremedhin, M., Cilwa, K. E. & Elster, E. A. Diagnostic bacteriology: Raman spectroscopy. Methods Mol Biol 1616, 249–261 (2017).
Lu, J. et al. Identification of antibiotic resistance and virulence-encoding factors in Klebsiella pneumoniae by Raman spectroscopy and deep learning. Microb Biotechnol 15, 1270–1280 (2022).
Yang, K., et al. An isotope-labeled single-cell Raman spectroscopy approach for tracking the physiological evolution trajectory of bacteria toward antibiotic resistance. Angew Chem Int Ed Engl 62, e202217412 (2023).
Germond, A. et al. Raman spectral signature reflects transcriptomic features of antibiotic resistance in Escherichia coli. Commun. Biol. 1, 85 (2018).
Li, H.-Z. et al. Phenotypic tracking of antibiotic resistance spread via transformation from environment to clinic by reverse D2O single-cell Raman probing. Anal Chem 92, 15472–15479 (2020).
Thomsen, B. L., et al. Accurate and fast identification of minimally prepared bacteria phenotypes using Raman spectroscopy assisted by machine learning. Sci Rep 12, 16436 (2022).
Wang, W. & Vikesland, P. J. Metabolite-mediated bacterial antibiotic resistance revealed by surface-enhanced Raman spectroscopy. Env. Sci Technol 57, 13375–13383 (2023).
Lorenz, B., Wichmann, C., Stockel, S., Rosch, P. & Popp, J. Cultivation-free Raman spectroscopic investigations of bacteria. Trends Microbiol 25, 413–424 (2017).
Kanno, N. et al. Machine learning-assisted single-cell Raman fingerprinting for in situ and nondestructive classification of prokaryotes. iScience 24, 102975 (2021).
Liu, Z., Xue, Y., Yang, C., Li, B. & Zhang, Y. Rapid identification and drug resistance screening of respiratory pathogens based on single-cell Raman spectroscopy. Front Microbiol 14, 1065173 (2023).
Kusic, D. et al. Raman spectroscopic differentiation of planktonic bacteria and biofilms. Anal. Bioanal. Chem 407, 6803–6813 (2015).
Li, H.-Z., et al. Active antibiotic resistome in soils unraveled by single-cell isotope probing and targeted metagenomics. PNAS 119, e2201473119 (2022).
Berus, S. M. et al. SERS-PLSR analysis of vaginal microflora: towards the spectral library of microorganisms. Int J Mol Sci 23, 12576 (2022).
Chen, Y., Premasiri, W. R. & Ziegler, L. D. Surface enhanced Raman spectroscopy of Chlamydia trachomatis and Neisseria gonorrhoeae for diagnostics, and extra-cellular metabolomics and biochemical monitoring. Sci Rep 8, 5163 (2018).
Cernava, T. et al. Metadata harmonization – standards are the key for a better usage of omics data for integrative microbiome analysis. Environ. Microbiome 17, 33 (2022).
Brownlie, E. J. E., Chaharlangi, D., Wong, E. O.-Y., Kim, D. & Navarre, W. W. Acids produced by lactobacilli inhibit the growth of commensal Lachnospiraceae and S24-7 bacteria. Gut Microbes 14, 2046452 (2022).
Zhao, Y. et al. Candida albicans infection disrupts the metabolism of vaginal epithelial cells and inhibits cellular glycolysis. Microorganisms 12, 292 (2024).
Tams, K. W. et al. The effects of antibiotic use on the dynamics of the microbiome and resistome in pigs. Anim Microbiome 5, 39 (2023).
Bickhart, D. M., et al. Assignment of virus and antimicrobial resistance genes to microbial hosts in a complex microbial community by combined long-read assembly and proximity ligation. Genome Biol 20, 153 (2019).
van der Helm, E. et al. Rapid resistome mapping using nanopore sequencing. Nucleic Acids Res 45, e61 (2017).
Pinheiro, E. T. et al. Metatranscriptome and resistome of the endodontic microbiome. J Endod 50, 1059–1072 (2024).
de Nies, L., Busi, S. B., Kunath, B. J., May, P. & Wilmes, P. Mobilome-driven segregation of the resistome in biological wastewater treatment. Elife 11, e81196 (2022).
Marcelino, V. R. et al. Meta-transcriptomics reveals a diverse antibiotics resistance gene pool in avian microbiomes. BMC Biol 17, 31 (2019).
Rohart, F., Gautier, B., Singh, A. & Le Cao, K.-A. mixOmics: An R package for ’omics feature selection and multiple data integration. PLoS Comput Biol 13, e1005752 (2017).
Ceccarani, C., et al. Diversity of vaginal microbiome and metabolome during genital infections. Sci Rep 9, 14095 (2019).
France, M. T., et al. Insight into the ecology of vaginal bacteria through integrative analyses of metagenomic and metatranscriptomic data. Genome Biol 23, 66 (2022).
